Coronavirus News and Research

RSS

Does high vaccine coverage among the adult population grant the unvaccinated younger population indirect protection against SARS-CoV-2?

Researchers investigated whether the mass vaccination of the adult population of Schwaz, Austria, against SARS-CoV-2 conferred an indirect protective effect on the proportion of unvaccinated children in the population.

3 Oct 2022

COVID-19 vaccination offers sustained and potent neutralizing protection against variants compared to natural infection

In a new study, researchers assessed the immunoglobulin (Ig)-G responses to SARS-CoV-2 after natural infection or vaccination.

3 Oct 2022

Novel linear DNA SARS-CoV-2 vaccine using electroporation-aided vaccine delivery reveals lower viral shedding in ferrets

Researchers evaluated the efficacy, immunogenicity, and safety of a novel SARS-CoV-2 linear deoxyribonucleic acid vaccine in ferret models delivered using intramuscular injection and electroporation.

3 Oct 2022

SARS-CoV-2-encoded protein ameliorates neuromuscular degeneration in fly models of neurodegenerative diseases

Researchers explored the in vivo efficacy of SARS-CoV-2-encoded proteins against neuromuscular degeneration associated with ribosome stalling.

3 Oct 2022

What were the effects of COVID-19 on our food choices?

In new research, a protocol was proposed to assess the effects of coronavirus disease 2019 (COVID-19) on eating behavior and food choices.

3 Oct 2022

What is the aerosol and droplet risk in COVID-19 transmission?

In a new study, researchers assessed the superposition of aerosol and droplet in COVID-19 transmission.

3 Oct 2022

Vaccine effectiveness of a second mRNA COVID-19 vaccine booster among nursing home residents

Researchers compared the effectiveness of double booster SARS-CoV-2 mRNA vaccinations and single booster vaccinations among nursing home residents in the US.

3 Oct 2022

Best-science guidance lost battle early during COVID-19 pandemic

Researchers used a mathematical model to depict how the general public drifted away from best-science guidance early during the COVID-19 pandemic.

3 Oct 2022

Broadly neutralizing antibodies are the blueprint for variant-proof, pansarbecovirus vaccines

A recent Nature Reviews Immunology study has summarized the efficacy of neutralizing antibodies that target four main regions of the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), namely, the receptor-binding domain (RBD) in the S1 subunit, the fusion peptide region in the S2 subunit, the stem helix region, and the N-terminal domain.

2 Oct 2022

Study reveals immune characteristics of long-COVID

Researchers perform antibody profiling against SARS-CoV-2, several endemic pathogens, as well as vaccine antigens among rheumatic disease patients.

2 Oct 2022

Vaccinated individuals infected with Omicron less likely to experience long COVID symptoms

Omicron infection and receipt of COVID-19 vaccines reduced the risk of PCC symptoms six months following infection.

2 Oct 2022

Structural analysis of monkeypox virus to guide the development of broad antiviral agents

In a new study, researchers explored the crystalline structure of the monkeypox (MPX) virus (MPXV) and the complex of VP39, a 2′-O-RNA methyltransferase (MTase) and sinefungin, a pan-MTase inhibitor.

30 Sep 2022

Brazilian study reveals the effects of SARS-CoV-2 infection on the central nervous system

A Brazilian study published in the journal PNAS describes some of the effects infection by SARS-CoV-2 can have on the central nervous system.

30 Sep 2022

Simple nasal wash can prevent hospitalization and deaths from COVID-19

Simple nasal washes with mild saline water can prevent hospitalization and deaths from COVID-19, if applied twice daily following a positive diagnosis, according to research led by the US-based Augusta University.

30 Sep 2022

Obscure family of viruses already endemic in African monkeys "poised for spillover" to humans

An obscure family of viruses, already endemic in wild African primates and known to cause fatal Ebola-like symptoms in some monkeys, is "poised for spillover" to humans, according to new University of Colorado Boulder research published online Sept. 30 in the journal Cell.

30 Sep 2022

Coronavirus News and Research

Does high vaccine coverage among the adult population grant the unvaccinated younger population indirect protection against SARS-CoV-2?

COVID-19 vaccination offers sustained and potent neutralizing protection against variants compared to natural infection

Novel linear DNA SARS-CoV-2 vaccine using electroporation-aided vaccine delivery reveals lower viral shedding in ferrets

SARS-CoV-2-encoded protein ameliorates neuromuscular degeneration in fly models of neurodegenerative diseases

What were the effects of COVID-19 on our food choices?

What is the aerosol and droplet risk in COVID-19 transmission?

Vaccine effectiveness of a second mRNA COVID-19 vaccine booster among nursing home residents

Best-science guidance lost battle early during COVID-19 pandemic

Broadly neutralizing antibodies are the blueprint for variant-proof, pansarbecovirus vaccines

Study reveals immune characteristics of long-COVID

Vaccinated individuals infected with Omicron less likely to experience long COVID symptoms

Structural analysis of monkeypox virus to guide the development of broad antiviral agents

Brazilian study reveals the effects of SARS-CoV-2 infection on the central nervous system

Simple nasal wash can prevent hospitalization and deaths from COVID-19

Obscure family of viruses already endemic in African monkeys "poised for spillover" to humans

The compositional and functional diversity of the gut fungal microbiome

SARS-CoV-2 spike protein and messenger ribonucleic acid found to translocate into the nucleus

What is the risk of Omicron infection in pregnant women?

Plasma proteome signature predictive of occurrence of persistent symptoms following SARS-CoV-2 infection

What is the efficacy of curcumin as a photosensitizer, prophylactic and therapeutic agent against SARS-CoV-2?

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News